Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Pneumagen Ltd
Sort By
Newest First
1 / 1
1 / 1
COVID-19 Treatment
Pneumagen Ltd Announces Positive Anti-Viral Activity for Novel Glycan Approach in Preventing Coronavirus Infections
Pneumagen
PR-M04-20-NI-038
Apr 28, 2020
Coronavirus
Pneumagen Ltd Leverages its Novel Glycan Approach to Target Coronavirus (COVID-19) Infections
Pneumagen
PR-M03-20-NI-024
Mar 17, 2020
